
Pandion Therapeutics, Inc. PAND
Pandion Therapeutics, Inc. Betriebszyklus | PAND
Betriebszyklus Jährlich Pandion Therapeutics, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 176 | 95 | 111 | 154 | 199 | 243 | 151 | 155 | 74.5 | 89 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 243 | 74.5 | 145 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioXcel Therapeutics
BTAI
|
1.66 K | $ 0.07 | 9.81 % | $ 855 K | ||
|
NeuBase Therapeutics
NBSE
|
-65.8 | - | -1.56 % | $ 12.3 M | ||
|
Gossamer Bio
GOSS
|
66.1 | $ 9.77 | 3.72 % | $ 2.23 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.1 K | - | - | $ 2.18 B | ||
|
GeoVax Labs
GOVX
|
48.4 | $ 0.16 | -5.0 % | $ 153 K | ||
|
Arena Pharmaceuticals
ARNA
|
8.16 K | - | -6.81 % | $ 3.04 B | ||
|
scPharmaceuticals
SCPH
|
447 | - | - | $ 218 M | ||
|
Xeris Pharmaceuticals
XERS
|
558 | $ 15.08 | 15.29 % | $ 2.42 B | ||
|
Athersys
ATHX
|
73 | - | 3.77 % | $ 22.4 M | ||
|
Zai Lab Limited
ZLAB
|
186 | $ 25.49 | 12.77 % | $ 27.9 B | ||
|
Zentalis Pharmaceuticals
ZNTL
|
22.6 | $ 1.71 | 2.05 % | $ 123 M | ||
|
Zoetis
ZTS
|
380 | $ 79.51 | -3.21 % | $ 35.3 B | ||
|
Global Blood Therapeutics
GBT
|
5.46 K | - | - | $ 4.62 B | ||
|
Idera Pharmaceuticals
IDRA
|
158 | - | -23.04 % | $ 26.6 M | ||
|
NanoString Technologies
NSTG
|
311 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
598 | - | -81.12 % | $ 4.28 M | ||
|
Sorrento Therapeutics
SRNE
|
125 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
7.98 | - | - | $ 59.7 M | ||
|
GlaxoSmithKline plc
GSK
|
0.04 | $ 50.28 | -0.27 % | $ 204 B | ||
|
Cocrystal Pharma
COCP
|
78.2 | $ 1.03 | 2.95 % | $ 11.6 M | ||
|
Vaccinex
VCNX
|
546 | - | -61.37 % | $ 654 K | ||
|
ImmuCell Corporation
ICCC
|
232 | $ 9.9 | -0.5 % | $ 89.4 M | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
17.9 | - | -19.68 % | $ 18.4 M | ||
|
Jounce Therapeutics
JNCE
|
2.32 | - | - | $ 98.4 M | ||
|
Verona Pharma plc
VRNA
|
136 | - | - | $ 69.7 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
361 | $ 306.2 | 2.41 % | $ 5.92 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
CymaBay Therapeutics
CBAY
|
175 | - | - | $ 3.45 B | ||
|
Timber Pharmaceuticals
TMBR
|
1.61 | - | - | $ 717 K |